Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 50,602,991 shares of Common Stock outstanding as of November 4, 2024, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 50,602,991 shares of Common Stock outstanding as of November 4, 2024, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 50,602,991 shares of Common Stock outstanding as of November 4, 2024, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 50,602,991 shares of Common Stock outstanding as of November 4, 2024, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.


SCHEDULE 13G



 
Canaan XI L.P.
 
Signature:/s/ Nancy Levenson
Name/Title:Nancy Levenson, Attorney-in-Fact
Date:01/21/2025
 
Canaan Partners XI LLC
 
Signature:/s/ Nancy Levenson
Name/Title:Nancy Levenson, Attorney-in-Fact
Date:01/21/2025
 
Canaan 2020+ Co-Investment L.P. - Series 7
 
Signature:/s/ Nancy Levenson
Name/Title:Nancy Levenson, Attorney-in-Fact
Date:01/21/2025
 
Canaan Partners 2020+ Co-Investment LLC
 
Signature:/s/ Nancy Levenson
Name/Title:Nancy Levenson, Attorney-in-Fact
Date:01/21/2025